Posts

Showing posts with the label Osteomyelitis - Pipeline Review

Osteomyelitis - Pipeline Review, H1 Industry Growth, Services, Sales and Overview To 2017

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Osteomyelitis - Pipeline Review, H1 2017, provides an overview of the Osteomyelitis (Infectious Disease) pipeline landscape. Osteomyelitis is an infection in a bone. Infections can reach a bone by traveling through the bloodstream or spreading from nearby tissue. Symptoms include fever, pain in the area of the infection, swelling, warmth and redness over the area of the infection and irritability. Risk factors bone fracture, sickle cell disease, chemotherapy, diabetes and peripheral arterial disease. Treatment includes surgery and oral antibiotics. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Osteomyelitis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Osteomyelitis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administr